PE20090070A1 - Derivados de furano como agentes antiinfecciosos - Google Patents

Derivados de furano como agentes antiinfecciosos

Info

Publication number
PE20090070A1
PE20090070A1 PE2008000274A PE2008000274A PE20090070A1 PE 20090070 A1 PE20090070 A1 PE 20090070A1 PE 2008000274 A PE2008000274 A PE 2008000274A PE 2008000274 A PE2008000274 A PE 2008000274A PE 20090070 A1 PE20090070 A1 PE 20090070A1
Authority
PE
Peru
Prior art keywords
ethinyl
pyrimidin
furan
tetrahydro
diol
Prior art date
Application number
PE2008000274A
Other languages
English (en)
Spanish (es)
Inventor
Zheng Yin
Jeyaraj Duraiswamy
Yen Liang Chen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39462074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090070(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20090070A1 publication Critical patent/PE20090070A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE2008000274A 2007-02-09 2008-02-07 Derivados de furano como agentes antiinfecciosos PE20090070A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07102027 2007-02-09
EP08150003 2008-01-02

Publications (1)

Publication Number Publication Date
PE20090070A1 true PE20090070A1 (es) 2009-03-19

Family

ID=39462074

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000274A PE20090070A1 (es) 2007-02-09 2008-02-07 Derivados de furano como agentes antiinfecciosos

Country Status (18)

Country Link
US (1) US8278282B2 (enExample)
EP (1) EP2132216B1 (enExample)
JP (1) JP2010518047A (enExample)
KR (1) KR20090109102A (enExample)
CN (1) CN101600726B (enExample)
AR (1) AR065249A1 (enExample)
AT (1) ATE533774T1 (enExample)
AU (1) AU2008212752A1 (enExample)
BR (1) BRPI0807222A2 (enExample)
CA (1) CA2675462A1 (enExample)
CL (1) CL2008000409A1 (enExample)
EA (1) EA200901080A1 (enExample)
ES (1) ES2381093T3 (enExample)
MX (1) MX2009008495A (enExample)
PE (1) PE20090070A1 (enExample)
PT (1) PT2132216E (enExample)
TW (1) TW200838550A (enExample)
WO (1) WO2008095993A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072906A1 (es) * 2008-08-06 2010-09-29 Novartis Ag Nucleosidos modificados utiles como antivirales
CN102526087B (zh) * 2010-12-30 2014-09-03 南开大学 核苷类化合物在制备治疗肠病毒71(ev71)感染疾病药物的应用
CN105669783B (zh) * 2014-12-03 2019-11-12 广东东阳光药业有限公司 一种制备呋喃糖的方法
WO2017024310A1 (en) 2015-08-06 2017-02-09 Chimerix, Inc. Pyrrolopyrimidine nucleosides and analogs thereof useful as antiviral agents
MX391226B (es) 2015-09-23 2025-03-21 Merck Sharp & Dohme Llc Inhibidores de transcriptasa inversa de nucleosido 4'-substituido y preparaciones de los mismos.
JP7129703B2 (ja) * 2016-04-28 2022-09-02 エモリー ユニバーシティー アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
TW201815821A (zh) * 2016-07-18 2018-05-01 美商再生元醫藥公司 抗茲卡病毒抗體及使用方法
US20190169221A1 (en) * 2016-08-12 2019-06-06 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2019060692A1 (en) 2017-09-21 2019-03-28 Chimerix, Inc. MORPHIC FORMS OF 4-AMINO-7- (3,4-DIHYDROXY-5- (HYDROXYMETHYL) -ETRAHYDROFURAN-2-YL) -2-METHYL-7H-PYRROLO [2,3-D] PYRIMIDINE-5-CARBOXAMIDE AND THEIR USES
WO2020219447A1 (en) 2019-04-23 2020-10-29 Elementis Specialties, Inc. Slurry compositions containing mixed branched alkyl organoclay compositions
EP4454650A4 (en) * 2021-12-22 2025-10-22 Cj Cheiljedang Corp ANTIVIRAL COMPOSITION COMPRISING NUCLEOSIDE ANALOGUES DERIVED FROM A NUCLEIC ACID AND A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
CN117430571B (zh) * 2022-07-15 2025-08-29 宜昌东阳光长江药业股份有限公司 一种制备吡喃葡萄糖基衍生物的关键中间体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1355916T1 (sl) * 2001-01-22 2007-04-30 Merck & Co Inc Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze
US7005448B2 (en) 2001-12-14 2006-02-28 Alcon, Inc. Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
WO2003068244A1 (en) * 2002-02-13 2003-08-21 Merck & Co., Inc. Methods of inhibiting orthopoxvirus replication with nucleoside compounds
KR20050006221A (ko) * 2002-05-06 2005-01-15 제네랩스 테크놀로지스, 인코포레이티드 Ｃ형 간염 바이러스 감염 치료용의 뉴클레오시드 유도체
US7425547B2 (en) * 2002-09-30 2008-09-16 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
US20040259934A1 (en) * 2003-05-01 2004-12-23 Olsen David B. Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
EP1680436A1 (en) * 2003-10-27 2006-07-19 Genelabs Technologies, Inc. Nucleoside compounds for treating viral infections

Also Published As

Publication number Publication date
BRPI0807222A2 (pt) 2014-04-29
WO2008095993A1 (en) 2008-08-14
AR065249A1 (es) 2009-05-27
EP2132216A1 (en) 2009-12-16
CN101600726A (zh) 2009-12-09
MX2009008495A (es) 2009-08-20
AU2008212752A1 (en) 2008-08-14
CN101600726B (zh) 2013-03-27
CA2675462A1 (en) 2008-08-14
EA200901080A1 (ru) 2010-02-26
TW200838550A (en) 2008-10-01
CL2008000409A1 (es) 2008-08-29
PT2132216E (pt) 2012-02-20
ES2381093T3 (es) 2012-05-23
JP2010518047A (ja) 2010-05-27
US20100227833A1 (en) 2010-09-09
KR20090109102A (ko) 2009-10-19
US8278282B2 (en) 2012-10-02
EP2132216B1 (en) 2011-11-16
ATE533774T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
PE20090365A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20210128A1 (es) Inhibidores de la ectonucleotido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos
PE20130012A1 (es) Derivados de pirazol como inhibidores de jak
PE20090326A1 (es) Compuestos heterociclos como inhibidores de erk
PE20061436A1 (es) Derivados de amida sustituida como inhibidores de proteina quinasa
PE20090511A1 (es) Imidazopiridinonas
PE20080704A1 (es) Inhibidores ns5b del virus hepatitis c de indolobenzazepina fusionados a ciclopropilo
PE20060837A1 (es) COMPUESTOS DE 3H-OXAZOLO Y 3H-TIAZOLO[4,5-d]PIRIMIDIN-2-ONA 3,5-DISUSTITUIDA Y 3,5,7-TRISUSTITUIDA Y PROFARMACOS DE LOS MISMOS
PE20210373A1 (es) Compuestos de pirimidina y composiciones farmaceuticas para prevenir o tratar canceres que incluyen los mismos
PE20171341A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas
PE20050462A1 (es) COMPUESTOS DE 5,7-DIAMINOPIRAZOLO[4,3-d]PIRIMIDINAS COMO INHIBIDORES DE LA FOSFODIESTERASA TIPO 5 (PDE-5)
PE20130395A1 (es) Pirazolo[1,5-a]pirimidinas para tratamiento antiviral
PE20171155A1 (es) Metodos y compuestos para tratar infecciones virales por paramyxoviridae
PE20120013A1 (es) Fosforamidato derivados de guanosina compuestos nucleosidos para tratamiento de infecciones virales
PE20110833A1 (es) Nuevas octahidrociclopenta[c]pirrol-4-aminas sustituidas como bloqueantes de los canales de calcio
PE20171449A1 (es) Derivados de nucleosidos sustituidos utiles como agentes antineoplasicos
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
SV2006002110A (es) Compuestos terapeuticos ref. pc32293a
PA8733401A1 (es) Compuestos de pirro[1,2-b]piridazinona
PA8804701A1 (es) Nucleosidos 2'4'-sustituidos como agentes antivirales
PE20110383A1 (es) Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a)
UY29458A1 (es) Heterociclos sustituidos y usos de los mismos
UY33097A (es) DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS
CR8249A (es) Forma cristalina gamma del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que lo contienen

Legal Events

Date Code Title Description
FD Application declared void or lapsed